Breast Cancer Clinical Trial
Official title:
Effects of a Group Residential Retreat on Cancer Outcomes
The goal of this behavioral research study is to compare 2 different types of residential group programs to help researchers learn if and how well these groups may help to improve physical and emotional well-being in patients with stage IV breast cancer.
Baseline Visit:
Signing this consent form does not mean that you will be able to take part in this study.
The following baseline tests will help the doctor decide if you are eligible:
- You will complete 7 questionnaires about your mood, sleep, fatigue, how you have been
feeling, and your general quality of life. The questionnaires should take about 60-80
minutes to complete.
- You will have an electroencephalogram (EEG) to check your brain's electrical activity.
During the EEG, a snug cap with small electrodes will be placed on your head to measure
the electrical patterns coming from the brain. This is like the way a doctor listens to
your heart from the surface of your skin. During the EEG, you will complete 3 tests to
check your attention, short-term memory, and levels of emotions on the computer. The
study staff will discuss each test in more detail with you. The EEG and tests will take
about 45-60 minutes total.
- If you have not had a computed tomography (CT) scan in the last 2 months, you will have
one performed to check the status of the disease. If you have had one in the last 2
months, the results will be collected from your medical records.
- You will have an electrocardiogram (EKG) to check your heart function.
- Blood (about 6 tablespoons) will be drawn for tests to measure hormones and your immune
system responses. You will need to fast (not eat or drink anything except water) for 12
hours before this blood draw. You will be provided with healthy snacks after your blood
draw.
The day after your baseline visit, saliva will be collected to measure the level of cortisol
(a type of stress hormone) in your body. These saliva samples will be collected 4 times each
day for 3 days in a row. You will collect these samples at home when you first wake up,
about 45 minutes later, about 10 hours after waking up, and then at bedtime. To collect each
saliva sample, you will chew on a cotton ball for a few seconds and then put the cotton in a
small plastic tube. You will write down the times you took these samples. You will mail
these samples back to MD Anderson in postage-paid envelopes that will be provided to you.
The tubes will also be provided at no cost to you. These saliva samples will be destroyed
after being studied.
Every day for the next 7 days after your baseline visit, you will fill out a diary about
your sleeping habits. You will also wear a special type of wrist watch for these 7 days. The
watch will collect data about your physical activity and sleeping habits. After you have
worn it for 7 days, you will mail the watch and the sleep diary back to MD Anderson in
postage-paid envelopes that will be provided to you.
Extended Baseline:
You will be asked to complete and provide all the same measures again 1 month after the
first baseline visit.
Study Groups:
If you are found to be eligible to take part in this study and you agree, you will be
randomly assigned (as in the roll of dice) to 1 of 3 study groups. This is done because no
one knows if one study group is better, the same, or worse than the other group.
- If you are assigned to Groups 1 or 2, you will take part in 1 of 2 types of residential
group programs.
- If you are assigned to Group 3, you will receive standard cancer care without any
participation in a residential group program.
If you are assigned to Groups 1 or 2, neither you nor the study staff will know what kind of
residential group program you are in.
Residential Support Program Sessions (Groups 1 and 2 only):
You will take part in a 7-day offsite, residential support program in groups of about 10
participants each. On Day 5 of the retreat, you will be joined by your spouse or caregiver.
During the 7 days, you will take part in group activities, learn relaxation skills, do
different cognitive activities (for example, reading, watching movies, and having group
discussions), and learn about mind-body connections. You will spend 7 days and 6 nights at
the residential retreat. Activities at the retreat will last about 12 hours per day with
breaks, group meals, and free time to rest in the morning, afternoon and evening, or as
needed.
At least 1 week before the retreat, you will be given a detailed agenda and schedule of all
activities that will occur during the retreat.
Follow-Up Sessions (All Groups):
You will complete the same tests/procedures that were performed at the baseline visit within
7 days after the residential program ends and then again about 3 months later. If you are in
Group 3, you will complete the same tests/procedures on the same schedule.
Length of Participation:
Your participation on this study will be over after you complete the follow-up sessions.
Depending on which study group you were assigned to, you may be able to take part in a
residential program that you did NOT previously take part in. The study chair or research
staff will discuss this option with you.
This is an investigational study.
Up to 100 participants and their caregivers will take part in this multicenter study. Up to
74 will be enrolled at MD Anderson.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |